Asbestos-Related Liabilities (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2026 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Movement in Liability for Asbestos and Environmental Claims [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Claims Activity | During the six months ended June 30, 2026, the Company paid $5 to settle asbestos claims and pay related legal and defense costs and had approximate claims activity as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Outstanding Asbestos Claims by Years of Exposure and State Filed | In the fourth quarter of each year, the Company performs an analysis of outstanding claims and categorizes these claims by year of exposure and state filed. As of December 31, 2025, the Company's outstanding claims were:
|
||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Percentage of Outstanding Claims Related to Claimants Alleging Serious Diseases | As of December 31, 2025 and 2024, the percentage of outstanding claims related to claimants alleging serious diseases (primarily mesothelioma and other malignancies) were as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||